Average percentage concordance for evDNA with the tumor was determined to be 100%, whereas for cfDNA concordance was lower with 88.89%, suggesting that evDNA may have a slight advantage for the detection of BRCA1 variants in patients (Figure 13C). The gene discussed is BRCA1; the disease is neoplasm.